Allogeneic marrow transplantation for treatment of leukemia: results of the Munich Cooperative Group.
Kolb
H J
HJ
Bender-Götze
C
C
Haas
R J
RJ
Thierfelder
S
S
Wilmanns
W
W
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D005860:Germany, West; D006086:Graft vs Host Disease / Q000517:prevention & control; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D007945:Leukemia, Lymphoid / Q000401:mortality / Q000628:therapy*; D007951:Leukemia, Myeloid / Q000401:mortality / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000628:therapy*; D012306:Risk; D013997:Time Factors; D014019:Tissue Donors
D006680:HLA Antigens